Ampio Pharmaceuticals

Ampio Pharmaceuticals is a development stage biopharmaceutical company focused on the discovery and development of novel therapies aimed at treating common inflammatory conditions for which there are limited treatment options. We are developing compounds that serve significant medical needs in osteoarthritis, diabetic macular edema, and other prevalent, inflammatory diseases through an innovative discovery and development platform.



Ampion™ for the treatment of osteoarthritis of the knee.

Learn About Ampion


Optina™ for the treatment of Diabetic Macular Edema.

Learn About Optina